These authors contributed equally to this work.
Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugs
Version of Record online: 8 MAR 2013
© 2013 Japanese Cancer Association
Volume 104, Issue 5, pages 573–583, May 2013
How to Cite
(Cancer Sci 2013; 104: 573–583)
- Issue online: 15 APR 2013
- Version of Record online: 8 MAR 2013
- Accepted manuscript online: 30 JAN 2013 05:19AM EST
- Manuscript Accepted: 22 JAN 2013
- Manuscript Revised: 21 JAN 2013
- Manuscript Received: 4 OCT 2012
|cas12117-sup-0001-FigS1.tif||image/tif||171K||Fig. S1. Drug sensitivities to gefitinib, erlotinib and SU11274 under sorting nexin (SNX) 1 knockdown. (A) Effect of SNX1 knockdown by SNX1 siRNA, as determined using immunoblotting. (B) Effect of SNX1 knockdown on expression of c-Met and EGFR in EBC-1 and PC-9 cells, as determined using immunoblotting. (C–E) Drug sensitivity of SNX1 siRNA-treated EBC-1 and PC-9 cells to gefitinib (C), erlotinib (D) and SU11274 (E), as determined using a cell viability assay.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.